STERIS (STE)
221.64
-1.37 (-0.61%)
At close: Mar 25, 2025, 3:59 PM
226.33
2.12%
Pre-market: Mar 26, 2025, 07:01 AM EDT
-0.61% (1D)
Bid | 214.81 |
Market Cap | 21.78B |
Revenue (ttm) | 5.39B |
Net Income (ttm) | 466.46M |
EPS (ttm) | 6.22 |
PE Ratio (ttm) | 35.63 |
Forward PE | 22.1 |
Analyst | Buy |
Ask | 235 |
Volume | 355,387 |
Avg. Volume (20D) | 523,691 |
Open | 223.79 |
Previous Close | 223.01 |
Day's Range | 219.17 - 224.48 |
52-Week Range | 197.82 - 248.24 |
Beta | 0.92 |
About STE
STERIS plc provides infection prevention and other procedural products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capit...
Industry Medical - Devices
Sector Healthcare
IPO Date Jun 1, 1992
Employees 18,000
Stock Exchange NYSE
Ticker Symbol STE
Website https://www.steris.com
Analyst Forecast
According to 5 analyst ratings, the average rating for STE stock is "Buy." The 12-month stock price forecast is $265, which is an increase of 19.56% from the latest price.
Stock ForecastsNext Earnings Release
STERIS is scheduled to release its earnings on May 7, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+3.55%
STERIS shares are trading higher. The company anno...
Unlock content with
Pro Subscription
4 months ago
-5.28%
Steris shares are trading lower after the company reported worse-than-expected Q2 revenue results